InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro Quality Score

51.4/100

Rank #1,531 of 2,960 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

KMDA Stock Analysis & AI Quality Score

Data updated 2026-09-12

AI stock analysis and institutional research for KAMADA LTD (KMDA), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores KMDA at 51.4/100 on a 32-signal composite quality model, placing it at rank #1,531 of 2,960 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q4 2025), KAMADA LTD reports quarterly revenue of $44.7M, net income of $3.6M. Top institutional holders of KMDA by reported 13-F value include Phoenix Financial Ltd., RENAISSANCE TECHNOLOGIES, WELLS FARGO & COMPANY, based on the most recent SEC filings. KMDA trades on the Nasdaq exchange and files with the SEC under CIK 1567529. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate KMDA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for KAMADA LTD directly from SEC EDGAR. KAMADA LTD's 13F Pro composite quality score has ranged between 50 and 54 since 2026, currently 51.4 — a stable long-term trajectory across 48 quarterly and live scoring snapshots.

Revenue

Q4 2025

$44.7M

Net Income

Q4 2025

$3.6M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+12.1% YoY
$180.5MFY 2025
FY22 $129.3MFY23 $142.5MFY24 $161.0MFY25 $180.5M

Total Assets

+1.7% YoY
$378.7MFY 2025
FY22 $322.4MFY23 $354.9MFY24 $372.3MFY25 $378.7M

Get alerted when KMDA's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for KAMADA LTD including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of KMDA

Companies Similar to KMDA

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

PLX

Protalix BioTherapeutics, Inc.

62
AI score
Similar quality profile · 3 shared holders
BWAY

Brainsway Ltd.

39
AI score
Similar quality profile · 3 shared holders
PAHC

PHIBRO ANIMAL HEALTH CORP

66
AI score
Similar quality profile · 3 shared holders
NATR

NATURES SUNSHINE PRODUCTS INC

51
AI score
Similar quality profile · 2 shared holders
PDEX

PRO DEX INC

63
AI score
Similar quality profile
ELMD

Electromed, Inc.

61
AI score
Similar quality profile · 1 shared holders
ADUS

Addus HomeCare Corp

65
AI score
Similar quality profile · 2 shared holders
HCSG

HEALTHCARE SERVICES GROUP INC

61
AI score
Similar quality profile · 1 shared holders

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put KMDA on your watchlist

Track score changes the day KAMADA LTD files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is KMDA a good stock to buy?

13F Pro's AI-powered analysis of KAMADA LTD (KMDA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for KMDA are available on the KMDA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. KMDA is classified as a small company.

Which hedge funds own KMDA?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling KMDA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of KAMADA LTD's investment landscape.